Q4 2026 launch plan · Internal

Easy Days

Easy Days. Earned Daily.

A 2 fl oz kava shot built for the shelf alongside feel free CLASSIC — a fully disclosed label and a second SKU that holds the door where kratom can't go.

172,800
Q4 unit plan

1,200 doors · 14,400 cases in the current sheet; pending confirmation.

Assumption — finalizing
$9.99
Shelf price

Everyday SRP · feel free CLASSIC is estimated around $8.00.

Assumption — finalizing
$5.91
After spend / case

$55 blended case less cost, sales trade, marketing and SG&A.

Assumption — finalizing
2 SKUs
Kava + Kratom · Kava + Caffeine

Two legal footprints, one distributor conversation.

2027 plan

From 1,200 doors this quarter to 10,350 by the end of 2027.

Justin's Year 1 plan from the shared sheet. All figures remain working assumptions until Ernie and Kyle finalize them.

$20.79M
2027 sales

4,536,000 units · $55.00 blended case

Assumption — finalizing
10,350
Retail doors by 2027 Q4

Kyle to update

Assumption — finalizing
378,000
2027 cases

12 units per case

Assumption — finalizing
$2.23M
After case spend

After cost, trade, marketing and SG&A · sheet calls this net revenue

Assumption — finalizing

2026 Q4

GA, PA, NJ

$792K
Rolling doors
1,200
Cases / door / month
4
Cases
14,400
Units
172,800

2027 Q1

IL, FL, RnR, WildSide

$2.38M
Rolling doors
3,600
Cases / door / month
4
Cases
43,200
Units
518,400

2027 Q2

VA, WI, NC, TBD

$3.56M
Rolling doors
5,400
Cases / door / month
4
Cases
64,800
Units
777,600

2027 Q3

TBD

$6.31M
Rolling doors
7,650
Cases / door / month
5
Cases
114,750
Units
1,377,000

2027 Q4

TBD

$8.54M
Rolling doors
10,350
Cases / door / month
5
Cases
155,250
Units
1,863,000

Spend per case

Blended case price
$55.00
COGS + freight · Pricing tab
($32.04)
Trade spend (12%) — sales line
($6.60)
Marketing spend (12%) — incl. POS
($6.60)
SG&A (7%)
($3.85)
Net per case
$5.91

Blended $55 case less $32.04 cost, 12% sales trade, 12% marketing and 7% SG&A. The sheet's “net revenue” is actually the amount left after all four costs, not accounting net revenue.

Still open in the sheet

  • Retail door counts and account-level forecast — Kyle to confirm
  • 2027 Q2 lists WI, but the earlier legal-state screen excludes Wisconsin — confirm SKU and compliance before treating those doors as available
  • Markets for 2027 Q3–Q4 and Q2's TBD market
  • Ecommerce dollars per quarter
  • COGS + freight per case — sheet still flags $32.04 for update
  • The sheet's 28,200 'total doors' adds rolling quarter-end doors; it is not unique doors — use 10,350 year-end doors

Additional funded ask in this sheet: $0.00. This does not establish total working-capital needs.

Work in progress · Source: 2027 easy day: JB 9_24_26 · Sheet1 (Google Sheets)

Distributor opportunity

$423K / month

Illustrative distributor replenishment opportunity, not incremental revenue to add to the 2027 plan. Source: Napkin Math - Counter Culture.

Beyond 2027

FY2 and FY3 are not in this workbook.

The full model page shows every tab of the current sheet; no earlier three-year projections are presented as current.

Working assumptions · Current 2027 workbook

The product

What we're putting on the shelf.

2 fl oz / 60 mL herbal supplement shot · 21+

Kava + Kratom

Wind-down after the work is done

Noble kava root, water-extracted, lab-verified plain leaf kratom, third-party tested every lot.

2 fl oz / 60 mL herbal supplement shot · 21+

Kava + Caffeine

Steadier, calmer kind of alert

Noble kava root only with a moderate caffeine dose. No kratom — sells where kratom cannot.

Where we attack

Where feel free (Botanic Tonics) is exposed.

Full disclosure on the front of the bottle

The category's biggest liability is labeling. Easy Days states Kava + Kratom plainly, 21+, with dose and warnings up front. That is a buyer-safety argument, not just a marketing line.

Two SKUs, two legal footprints

Kava + Caffeine holds shelf where kratom is restricted. A one-SKU competitor loses the door entirely; Easy Days keeps the account.

Lab-tested every lot, published

Third-party testing per lot, made available to the buyer. Matches the compliance bar the category leader had to build after the fact.

Creator Collective instead of paid category ads

16.5% attributed commission on a 21+ creator roster — acquisition cost scales with sales instead of front-loading media spend.

Interpretation based on public reporting and Botanic Tonics' own releases — see the investor page for sources.

Still open

What we owe each other this week.

ItemStatusOwner
Q4 unit commitment172,800 units (14,400 cases, 1,200 doors) in the current sheet. Final pending door counts from Kyle.Ernie + Kyle
Full sales forecast buildThe sheet projects 378,000 cases in 2027; account-level forecast and market spend allocation still need confirmation.Ernie + Kyle
Overall pricing modelPricing tab (WIP): $9.99 everyday SRP / $7.99 promo 4x/yr, $5.00 wholesale, $5.50 to retail via DSD (24.24% margin), $2.67 unit COGS.Ernie + Kyle
Confirmed COGS on RNPricing tab carries $2.67/bottle ($32.04/case). Awaiting landed-cost confirmation.Ops
Trade spend envelopeStructure agreed (trade in sales, POS in marketing). Dollar envelope pending the forecast.Sales + Marketing
Distributor target listCounter Culture napkin math lists accounts and $423,250 monthly replenishment potential; conversion into the 2027 door plan is unconfirmed.Sales
Field team pay plan$25/hr + 10/20/30% commission tiers designed. Needs Shiky/Tom sign-off before hiring; door-opening bonus and reorder % still TBD.Shiky / Tom, Kyle + Alex
Field team budget (Year 1)$840K–$1.42M penciled for 9 reps, 3 regional managers, President of Sales. Largest line item; pending Alex.Alex
Working assumptions · pending founder review